Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.
Trials
; 23(1): 444, 2022 May 25.
Article
in En
| MEDLINE
| ID: mdl-35614482
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulonephritis, IGA
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
Reino Unido